Category: Oncology

From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research

The word "cancer" was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to its naming, descriptions of human cancer can be traced back...

/ September 29, 2020

Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people you can run into in the hallway. She is also...

/ July 27, 2020

Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a Lecturer in Molecular Oncology and Protein Science at the University...

/ June 22, 2020

Why is Digital Spatial Profiling Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D

“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and complex genomes I had ever seen”. Troy McEachron, Ph.D The first...

/ June 15, 2020

Readers’ Favorite Webinars: A Year in Review

NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions.  They have always been a crowd-pleaser, so in 2019 we decided to showcase and summarize them...

/ March 2, 2020